(Q41712968)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25290234%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

title

Pseudomonas aeruginosa eradicates Staphylococcus aureus by manipulating the host immunity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25290234%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

main subject

Staphylococcus aureus

1 reference

inferred from title

Pseudomonas aeruginosa

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25290234%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Pierre Regis Burgel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25290234%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Clémence Martin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25290234%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Gérard Lambeau

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25290234%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Dorota Sands

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25290234%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

13

Lhousseine Touqui

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25290234%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Erwan Pernet

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25290234%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Isabelle Sermet-Gaudelus

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25290234%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Dominique Leduc

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25290234%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Philippe C Morand

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25290234%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Louise Jeammet

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25290234%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Michel Chignard

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25290234%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Yongzheng Wu

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25290234%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

language of work or name

English

0 references

publication date

7 October 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25290234%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

published in

Nature Communications

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25290234%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25290234%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

5105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25290234%20AND%20SRC:MED&resulttype=core&format=json

Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life

20 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

The changing microbial epidemiology in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Identification of the cystic fibrosis gene: genetic analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Cystic fibrosis: a mucosal immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Cystic fibrosis infections: treatment strategies and prospects.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Clinical significance of microbial infection and adaptation in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Chronic Pseudomonas aeruginosa infection definition: EuroCareCF Working Group report.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Lower airway inflammation in infants and young children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Microbial ecology of the cystic fibrosis lung

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Antibacterial actions of secreted phospholipases A2. Review

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Mammalian secreted phospholipases A2 and their pathophysiological significance in inflammatory diseases

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

https://api.crossref.org/works/10.1038%2FNCOMMS6105

1 reference

7 January 2021

Type-IIA secreted phospholipase A2 is an endogenous antibiotic-like protein of the host

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Recent progress in phospholipase A₂ research: from cells to animals to humans

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

In vivo protective role of human group IIa phospholipase A2 against experimental anthrax

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Cell-wall determinants of the bactericidal action of group IIA phospholipase A2 against Gram-positive bacteria.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Biochemical characterization of selective inhibitors of human group IIA secreted phospholipase A(2) and hyaluronic acid-linked inhibitor conjugates

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Secreted group IIA phospholipase A2 protects humans against the group B streptococcus: experimental and clinical evidence.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Time-resolved fluoroimmunoassays of the complete set of secreted phospholipases A2 in human serum

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Expression of human group II PLA2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Analysis of expression of secreted phospholipases A2 in mouse tissues at protein and mRNA levels.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

A Cystic Fibrosis Bronchial Epithelial Cell Line: Immortalization by Adeno-12-SV40 Infection

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Activities of Pseudomonas aeruginosa effectors secreted by the Type III secretion system in vitro and during infection

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

The type III secretion system of Pseudomonas aeruginosa: infection by injection

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Characterization of Pseudomonas aeruginosa exoenzyme S as a bifunctional enzyme in J774A.1 macrophages

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Pseudomonas aeruginosa infection of airway epithelial cells modulates expression of Kruppel-like factors 2 and 6 via RsmA-mediated regulation of type III exoenzymes S and Y.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Interaction between Pseudomonas aeruginosa and Staphylococcus aureus: description of an anti-staphylococcal substance

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Staphylococcus aureus serves as an iron source for Pseudomonas aeruginosa during in vivo coculture

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Pattern differentiation in co-culture biofilms formed by Staphylococcus aureus and Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Roles of secretory phospholipases A(2) in inflammatory diseases and trauma

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Bactericidal properties of group IIa secreted phospholipase A2 against Pseudomonas aeruginosa clinical isolates

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Wall teichoic acid deficiency in Staphylococcus aureus confers selective resistance to mammalian group IIA phospholipase A(2) and human beta-defensin 3

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Human Neutrophils Store Type II 14-kDa Phospholipase A2 in Granules and Secrete Active Enzyme in Response to Soluble Stimuli

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Determinants of activation by complement of group II phospholipase A2 acting against Escherichia coli.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Impact of CFTR DeltaF508 mutation on prostaglandin E2 production and type IIA phospholipase A2 expression by pulmonary epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Role of Pseudomonas aeruginosa type III effectors in disease

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Pseudomonas aeruginosa cystic fibrosis isolates induce rapid, type III secretion-dependent, but ExoU-independent, oncosis of macrophages and polymorphonuclear neutrophils

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Mammalian Krüppel-Like Factors in Health and Diseases

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Abrogation of anti-inflammatory transcription factor LKLF in neutrophil-dominated airways

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Bacterial toxins induce sustained mRNA expression of the silencing transcription factor klf2 via inactivation of RhoA and Rhophilin 1.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

TLR2- and nucleotide-binding oligomerization domain 2-dependent Krüppel-like factor 2 expression downregulates NF-kappa B-related gene expression.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

High bactericidal efficiency of type iia phospholipase A2 against Bacillus anthracis and inhibition of its secretion by the lethal toxin

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Bactericidal group IIA phospholipase A2 in serum of patients with bacterial infections

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

A novel bacterial resistance mechanism against human group IIA-secreted phospholipase A2: role of Streptococcus pyogenes sortase A.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Bactericidal properties of murine intestinal phospholipase A2.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

The antimicrobial activity of the cathelicidin LL37 is inhibited by F-actin bundles and restored by gelsolin

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Beta-defensins and LL-37 in bronchoalveolar lavage fluid of patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Genotypic and phenotypic analysis of type III secretion system in a cohort of Pseudomonas aeruginosa bacteremia isolates: evidence for a possible association between O serotypes and exo genes.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Isolation of an IHF-deficient mutant of a Pseudomonas aeruginosa mucoid isolate and evaluation of the role of IHF in algD gene expression.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Control of Pseudomonas aeruginosa in the lung requires the recognition of either lipopolysaccharide or flagellin

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

A Natural Disruption of the Secretory Group II Phospholipase A2 Gene in Inbred Mouse Strains

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

IL-10 delivery by AAV5 vector attenuates inflammation in mice with Pseudomonas pneumonia

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Reduction in viscosity of cystic fibrosis sputum in vitro by gelsolin

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

DNA concentration and length in sputum of patients with cystic fibrosis during inhalation with recombinant human DNase

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Reversible envelope effects during and after killing of Escherichia coli w by a highly-purified rabbit polymorpho-nuclear leukocyte fraction

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Involvement of secretory phospholipase A2 activity in the zymosan rat air pouch model of inflammation

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

Intranasal steroids decrease eosinophils but not mucin expression in nasal polyps.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021

CFTR dysfunction induces vascular endothelial growth factor synthesis in airway epithelium.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS6105

7 January 2021